Ute Boronowsky, Author at Labiotech.eu

About

Ute Boronowsky obtained a PhD in plant biochemistry at the Ruhr-University Bochum in 1999. After her postdoc at UCLA, she moved to the biotech industry and worked in various sales and marketing positions. Since 2015, she works as a freelance science and marketing writer, translator, and journalist.

Articles by Ute Boronowsky

ASEBIO, BIOSPAIN 2023

23 May 2023

20 years of BIOSPAIN – The evolution of an international biotech event

This year marks the 20th anniversary of BIOSPAIN, an international meeting showcasing new developments in biotech and also a benchmark partnering event. From September 26-28, 2023, BIOSPAIN will return to…

May 23, 2023 - 5 minutesmins - By Ute Boronowsky

PL BioScience, ELAREM, GMP-compliant supplements, cell therapy

25 Apr 2023

Becoming human: GMP-compliant supplements for cell therapy

Media additives, or supplements, are indispensable for cell growth and vitality, as they deliver vitamins, energy sources, and various other essential growth factors. However, current animal-sourced supplements are poorly compatible…

April 25, 2023 - 5 minutesmins - By Ute Boronowsky

B2B Intravasation02

21 Feb 2023

From breast to bone: Refining metastasis drug discovery with a novel organ-on-a-chip device

Understanding invasive cancer progression and metastasis formation are among the core open questions in cancer research. However, the limitations of current models lead to high failure rates in drug development.…

February 21, 2023 - 6 minutesmins - By Ute Boronowsky

inventory management laboratory lanexo system

14 Feb 2023

How efficient lab inventory management can become a driver for success

Lab inventory management is often not the first priority of biotech companies trying to stay ahead in a competitive environment. But according to a report released by the EU commission,…

February 14, 2023 - 5 minutesmins - By Ute Boronowsky

ADVERTISEMENT

How clinical trials benefit from decentralized solutions: A Nordic case study

26 Jan 2023

How clinical trials benefit from decentralized solutions: A Nordic case study

Digitization is changing the way clinical trials are conducted. Spurred by the pandemic, decentralized clinical trials are on the rise, with clear benefits for clinicians and patients. Three Nordic companies…

January 26, 2023 - 6 minutesmins - By Ute Boronowsky

cover photo 1

23 Dec 2022

Transforming customer journeys, one step at a time: An interview with Mike Chen, CEO of ACROBiosystems

Customer journeys are very individual as each customer has different needs, and each manufacturer has its own philosophy regarding product development. To ACROBiosystems, bridging the gap between customer and manufacturer…

December 23, 2022 - 6 minutesmins - By Ute Boronowsky

circulating tumor cells, cancer, clinical trials

26 Jul 2022

Using the full potential of circulating tumor cells for oncology clinical trials

Circulating tumor cell counts are powerful prognostic factors for cancer patients. Recent research has found that they can be quite heterogeneous – similar to the cells of the tumor they…

July 26, 2022 - 5 minutesmins - By Ute Boronowsky

FBZ 7626 1 scaled

21 Jul 2022

You need to reach market readiness? What now?

Advancing a drug to market readiness is a major milestone. After successfully completing clinical studies, manufacturing and analytical processes must be adapted and optimized for commercial scale. Partnering with an…

July 21, 2022 - 6 minutesmins - By Ute Boronowsky

covid-19 vaccine bottles, manufacture supply line, vaccine development

23 Jun 2022

How a global network accelerated the development of a virus-like particle vaccine against Covid-19

Vaccines are among the most effective ways to improve and protect human health. Whereas vaccines in Europe and North America are regarded as part of the general medical plan, vaccine…

June 23, 2022 - 5 minutesmins - By Ute Boronowsky

DNA, DNA double-helix

7 Jun 2022

Gene therapy: can CDMOs solve the manufacturing bottleneck?

The gene therapy market is booming. Viral vectors, the key delivery systems for gene therapies, are playing an increasing role in the development of biologics. But the growing need for…

June 7, 2022 - 7 minutesmins - By Ute Boronowsky

shutterstock 1109342633

19 Apr 2022

How a Berlin-Based Biotech Pushes the Limits of Immune Cell Monitoring

Immune cell monitoring is imperative for almost any clinical study. The problem: Current procedures require viable cells, a demand often torpedoed by sample logistics. [caption id="attachment_80378" align="alignleft" width="300"] Eva Raschke,…

April 19, 2022 - 5 minutesmins - By Ute Boronowsky

biostatistics, biostatistician, clinical trial management

4 Jan 2022

Why Biostatisticians are Essential for Successful Clinical Trial Management

The role of biostatisticians goes far beyond analyzing data at the end of a clinical study. Instead, they should be involved in clinical trial management right from the start to…

January 4, 2022 - 5 minutesmins - By Ute Boronowsky

Charles River Laboratories, off-target effects, drug development, cell microarray technology, cell microarrays, Retrogenix

21 Dec 2021

Using Cell Microarrays to Detect Off-Target Effects in Drug Development

A primary concern in drug development is the binding of drugs to targets they are not supposed to bind to. As a result, off-target effects can occur, which may have…

December 21, 2021 - 5 minutesmins - By Ute Boronowsky

CDMO, drug development, CDMO alliance, commercialization, Vetter, Rentschler

6 Jul 2021

How a CDMO Alliance Sets New Standards for Drug Development and Commercialization

To speed up drug development and commercialization, most biotechs partner with contract development and manufacturing organizations (CDMOs). Often though, they need to coordinate their project with more than one CDMO,…

July 6, 2021 - 5 minutesmins - By Ute Boronowsky

Muralla Pamplona, Biospain 2021, Spain, biotech, partnering conference, partnering event

8 Jun 2021

Why BIOSPAIN 2021 Could Become a Reunion Event for the Biotech Industry

Partnering events are unique opportunities for biotechs to present their projects to potential investors and secure funding. These meetings are complemented by trade shows, presentations, and networking events. BIOSPAIN 2021…

June 8, 2021 - 5 minutesmins - By Ute Boronowsky

shutterstock 1352838686

6 Apr 2021

Data Management: Taking the Right Turn at the Clinical Trial Crossroads

The success of a new drug depends on much more than its efficacy and safety or the ingenuity of its developers. Each clinical trial has multiple decision points, and taking…

April 6, 2021 - 5 minutesmins - By Ute Boronowsky

ADVERTISEMENT

FBZ 9494 scaled e1615299058824

17 Mar 2021

Afraid of Tech Transfer? There’s No Need!

Tech transfer appears on the agenda of almost every biotech company. After identifying a suitable molecule, biotechs need support from external partners on the way to commercialization. However, many fear…

March 17, 2021 - 6 minutesmins - By Ute Boronowsky

shutterstock 571381327 scaled e1611661148463

2 Feb 2021

Sample Processing & Management – Hidden Success Factors in Clinical Trials

Standardized, carefully managed samples are indispensable for the success of any clinical study. Still, sample processing and management receive little attention. Clinical trials studying immuno-oncology treatments, auto-immune therapeutics, cell therapies,…

February 2, 2021 - 5 minutesmins - By Ute Boronowsky

HEADER Clarivate

11 Nov 2020

Why Biotech Fundraising is at a Record High

In 2020, fundraising seems like an even bigger challenge than before. The biotech industry, however, is seeing a record high in capital raised to finance new therapeutic developments. [caption id="attachment_80881"…

November 11, 2020 - 4 minutesmins - By Ute Boronowsky

Header Merck

7 Sep 2020

Bioburden Detection: The Hidden Bottleneck in Drug Manufacturing

Bioburden detection is one of the quality control measures required to ensure drug safety – and a possible bottleneck for product release. Most of the challenges of drug development are…

September 7, 2020 - 5 minutesmins - By Ute Boronowsky

Newsletter Signup

"*" indicates required fields